Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigious | ||
| Readability |
H.S. freshman Avg
|
|
New words:
abstained, ALROPANE, Arthur, ASIA, assumption, bankruptcy, biasing, bioaxone, BM, borrow, borrowed, calendar, cervical, CETHRIN, CMCC, comparison, conferring, Connecticut, country, curtain, curve, deactivate, decompression, derecognition, DMC, dual, enrich, EU, FAS, fibrin, fit, forfeiture, Foundation, fusion, Haven, hour, inactivating, inactivation, infection, input, intractable, involuntary, iron, Japan, judged, Koenig, Lender, light, LLP, mixed, ofForm, ofRegulation, onForm, open, Orphan, path, PCP, perpetual, petition, plain, platform, preexisting, quantification, quantify, Quantifying, ratify, repair, RG, Rho, Scale, SCI, scored, sealant, sensory, sizable, spine, stabilize, TG, thisForm, thoracic, transformation, turn, unfavorable, unsecured, upcoming, urinary, vanilla, violate, William, worth, Zhigang
Removed:
abnormal, Academy, adenosine, adolescence, affiliation, Alan, algorithm, alive, Amersham, analytic, axonal, blockage, Canton, caption, cell, Chemic, clot, correction, coupon, cytoprotective, debility, Depending, diabetic, differentiation, dissolution, distinct, Doylestown, examination, failed, Fischman, Force, fundamental, global, GMP, hematological, hemodynamic, highest, individually, inflammation, ischemic, largely, manifest, minimizing, moderate, Nycomed, originating, owing, Pennsylvania, personality, play, positron, predisposing, presynaptic, ProCell, propriety, quadrant, Radiology, random, readily, released, reliable, repaid, researcher, resting, retinopathy, revealed, reversing, sector, shareholder, sourcing, sprouting, step, streamlined, strong, switch, team, text, thought, tissue, transporter, Troponin, vessel, vivo
Filing tables
Filing exhibits
- 10-K Annual report
- 10.30 EX-10.30 Non-employee Director Compensation Summary
- 10.31 EX-10.31 Executive Officer Compensation Summary
- 10.52 EX-10.52 Nonstatutory Stock Option Agreement (Peter Savas)
- 10.53 EX-10.53 Nonstatutory Stock Option Agreement (Mark Rykett)
- 10.54 EX-10.54 Nonstatutory Stock Option Agreement (Ken Rice)
- 21 EX-21 Subsidiaries
- 23.1 EX-23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 EX-31.1 Section 302 Certification of CEO
- 31.2 EX-31.2 Section 302 Certification of CFO
- 32.1 EX-32.1 Section 906 Certification of CEO
- 32.2 EX-32.2 Section 906 Certification of CFO
Alseres Pharmaceuticals similar filings
External links